InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,719.22
(
0.29%
)
US TECH 100
19,318.40
(
0.11%
)
Dow Jones
42,133.61
(
0.17%
)
Brent Oil
73.47
(
-0.56%
)
Bitcoin
63,391.48
(
-0.36%
)
Post# of 658989
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1260
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Monday, 02/05/2024 2:49:21 PM

Monday, February 05, 2024 2:49:21 PM

Post# of 658989
UNCY $0.95 Blockbuster Phase 3 data in Q2 , has very low valuation of only 35 million .Over 5 million shares added by institutional investors in last weeks .

https://finance.yahoo.com/news/unicycive-therapeutics-issues-shareholder-letter-120300698.html
Topline Data from OLC Pivotal Trial Expected in Q2 2024 –– OLC will target the multibillion-dollar hyperphosphatemia market.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up